Serial 79201268
Live / Registered — Cancelled — Section 71 (as of 10 Jan 2025)
What this means for you
Registered since 26 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79201268
- Registration number
- 5499785
- Mark type
- Design / logo
- Filed
- 10 Oct 2016
- Published for opposition
- 10 Apr 2018
- Registered
- 26 Jun 2018
- Attorney of record
- Beth E. Cooperstein
Goods and services
- Class 001 — Chemicals: Chemical products for use in science, namely, polymers for the manufacture of pharmaceutical preparations, oligomers for the manufacture of pharmaceutical preparations, small organic compounds being hydro-carbonated compounds used in biotechnology research and the manufacture of pharmaceuticals preparations, molecules comprising carbon, hydrogen and oxygen atoms used in biotechnology research and the manufacture of pharmaceuticals preparations, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, polypeptides for in vitro research use and proteins for the manufacture of pharmaceutical preparations for the treatment of diabetes; chemical products for use in the medical and pharmaceutical industries, namely, polymers for the manufacture of pharmaceutical preparations, oligomers for the manufacture of pharmaceutical preparations, small organic compounds being hydro-carbonated compounds used in biotechnology research and the manufacture of pharmaceuticals preparations, molecules comprising carbon, hydrogen and oxygen atoms used in biotechnology research and the manufacture of pharmaceuticals preparations, peptides substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, polypeptides for in vitro research use and proteins for the manufacture of pharmaceutical preparations for the treatment of diabetes
- Class 005 — Pharmaceuticals: Chemical products intended to be integrated in medicines so as to improve their effectiveness, namely, pharmaceutical excipients sold as an integral component of medicines so as to promote dissemination in a given area of the human body; pharmaceutical excipients, namely, drug delivery agents consisting of chemical compounds that improve delivery of a wide range of pharmaceuticals; pharmaceutical substances for medical use, namely for treatment of diabetes; pharmaceutical and veterinary products, namely for treatment of diabetes
- Class 042 — Scientific and technological services: Medical research; scientific and technological services, namely, scientific analysis, scientific research and development and design and testing of new products for others, clinical research, all in the field of treatment of diabetes
Owner
Prosecution history
- 05 Mar 2026 — TOTAL INVALIDATION PROCESSED BY THE IB
- 14 Feb 2026 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 14 Feb 2026 — INVALIDATION PROCESSED
- 10 Sept 2025 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 10 Sept 2025 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 10 Jan 2025 — CANCELLED SECTION 71
- 26 Jun 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 19 Oct 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Sept 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Sept 2018 — FINAL DISPOSITION PROCESSED
- 26 Sept 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 10 Apr 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Apr 2018 — PUBLISHED FOR OPPOSITION
- 06 Apr 2018 — NOTIFICATION PROCESSED BY IB